Replication and single-cycle delivery of SARS-CoV-2 replicons.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
26 Nov 2021
Historique:
pubmed: 15 10 2021
medline: 15 12 2021
entrez: 14 10 2021
Statut: ppublish

Résumé

Molecular virology tools are critical for basic studies of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and for developing new therapeutics. Experimental systems that do not rely on viruses capable of spread are needed for potential use in lower-containment settings. In this work, we use a yeast-based reverse genetics system to develop spike-deleted SARS-CoV-2 self-replicating RNAs. These noninfectious self-replicating RNAs, or replicons, can be trans-complemented with viral glycoproteins to generate replicon delivery particles for single-cycle delivery into a range of cell types. This SARS-CoV-2 replicon system represents a convenient and versatile platform for antiviral drug screening, neutralization assays, host factor validation, and viral variant characterization.

Identifiants

pubmed: 34648371
doi: 10.1126/science.abj8430
pmc: PMC9007107
mid: NIHMS1788959
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Antiviral Agents 0
NSP1 protein, SARS-CoV-2 0
RNA, Viral 0
Spike Glycoprotein, Coronavirus 0
Viral Nonstructural Proteins 0
spike protein, SARS-CoV-2 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1099-1106

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150275
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116943
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI091707
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA213359
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190261
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124690
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI138938
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA213448
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Organisme : NIAID NIH HHS
ID : R03 AI141855
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM109824
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143295
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI142010
Pays : United States

Références

Elife. 2020 Oct 28;9:
pubmed: 33112236
Antiviral Res. 2020 Nov;183:104939
pubmed: 32980446
Cell. 2020 Nov 25;183(5):1325-1339.e21
pubmed: 33080218
Cell Host Microbe. 2020 Dec 9;28(6):880-891.e8
pubmed: 33242391
J Virol. 1988 May;62(5):1687-96
pubmed: 2833619
Methods Mol Biol. 2020;2203:167-184
pubmed: 32833212
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
J Virol. 2008 Nov;82(22):11318-30
pubmed: 18753196
Science. 2020 Sep 4;369(6508):1249-1255
pubmed: 32680882
Annu Rev Virol. 2015 Nov;2(1):265-88
pubmed: 26958916
Redox Biol. 2020 Sep;36:101682
pubmed: 32810737
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
J Virol. 1993 Nov;67(11):6439-46
pubmed: 8411346
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Med Microbiol Immunol. 2019 Feb;208(1):3-24
pubmed: 30298360
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Antiviral Res. 2021 Jan;185:104974
pubmed: 33217430
Cell Rep. 2021 Apr 20;35(3):109014
pubmed: 33838744
Curr Gene Ther. 2005 Aug;5(4):387-98
pubmed: 16101513
Science. 1999 Jul 2;285(5424):110-3
pubmed: 10390360
Nat Commun. 2021 May 11;12(1):2642
pubmed: 33976134
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0009721
pubmed: 33903110
RNA. 2020 Dec 2;:
pubmed: 33268501
J Virol. 2008 May;82(9):4471-9
pubmed: 18305050
Nature. 2021 Jun;594(7862):240-245
pubmed: 33979833
PLoS Pathog. 2021 Mar 12;17(3):e1009439
pubmed: 33711082
Science. 2021 Aug 20;373(6557):931-936
pubmed: 34285133
J Virol. 2012 Dec;86(24):13598-608
pubmed: 23035226
J Virol. 2002 Feb;76(3):1422-34
pubmed: 11773416
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
J Gen Virol. 2008 Sep;89(Pt 9):2157-2166
pubmed: 18753225
Nat Struct Mol Biol. 2009 Nov;16(11):1134-40
pubmed: 19838190
Cell. 2021 Jan 7;184(1):120-132.e14
pubmed: 33382968
J Biol Chem. 1989 May 25;264(15):8935-40
pubmed: 2498321
J Natl Cancer Inst. 1973 Nov;51(5):1417-23
pubmed: 4357758
Cell. 2021 Jan 7;184(1):133-148.e20
pubmed: 33338421
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33479166
Int J Biol Sci. 2021 Apr 10;17(6):1574-1580
pubmed: 33907521
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Cell. 2021 Apr 15;184(8):2229-2238.e13
pubmed: 33691138
Science. 2005 Jul 22;309(5734):623-6
pubmed: 15947137
Drug Discov Today. 2020 Jun;25(6):1026-1033
pubmed: 32272194
J Virol. 1987 May;61(5):1457-65
pubmed: 3573144
Nat Struct Mol Biol. 2020 Oct;27(10):959-966
pubmed: 32908316
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
Nat Commun. 2019 Jan 10;10(1):120
pubmed: 30631056
J Virol. 2011 May;85(10):4963-73
pubmed: 21389138
Lancet Microbe. 2020 May;1(1):e2-e3
pubmed: 32835319
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Crit Care Res Pract. 2010;2010:
pubmed: 20948883
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33766889
Chromosoma. 2016 Sep;125(4):621-32
pubmed: 27116033
J Virol. 2001 Jul;75(14):6676-81
pubmed: 11413334
Emerg Microbes Infect. 2020 Dec;9(1):680-686
pubmed: 32207377
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
mBio. 2021 Jan 19;12(1):
pubmed: 33468688
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
J Biol Chem. 1993 Feb 5;268(4):2719-26
pubmed: 8428945
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
PLoS Biol. 2021 Feb 25;19(2):e3001091
pubmed: 33630831
Genome Res. 2001 Jun;11(6):1095-9
pubmed: 11381035
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
J Virol. 2005 Mar;79(5):2689-99
pubmed: 15708988
Nucleic Acids Res. 1998 Nov 15;26(22):5073-8
pubmed: 9801302
Science. 2000 Dec 8;290(5498):1972-4
pubmed: 11110665
J Gen Virol. 2004 Jun;85(Pt 6):1717-1725
pubmed: 15166457
Viruses. 2020 May 06;12(5):
pubmed: 32384820
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
J Virol. 2020 Aug 17;94(17):
pubmed: 32571797

Auteurs

Inna Ricardo-Lax (I)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Joseph M Luna (JM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Tran Thi Nhu Thao (TTN)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.

Jérémie Le Pen (J)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Yingpu Yu (Y)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

H-Heinrich Hoffmann (HH)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

William M Schneider (WM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Brandon S Razooky (BS)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Javier Fernandez-Martinez (J)

Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, NY 10065, USA.

Fabian Schmidt (F)

Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.

Yiska Weisblum (Y)

Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.

Bettina Salome Trüeb (BS)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Inês Berenguer Veiga (I)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Kimberly Schmied (K)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Nadine Ebert (N)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Eleftherios Michailidis (E)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Avery Peace (A)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Francisco J Sánchez-Rivera (FJ)

Cancer Biology and Genetics, MSKCC, New York, NY 10065, USA.

Scott W Lowe (SW)

Cancer Biology and Genetics, MSKCC, New York, NY 10065, USA.

Michael P Rout (MP)

Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, NY 10065, USA.

Theodora Hatziioannou (T)

Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.

Paul D Bieniasz (PD)

Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.

John T Poirier (JT)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA.

Margaret R MacDonald (MR)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Volker Thiel (V)

Institute of Virology and Immunology (IVI), Bern, Switzerland.
Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

Charles M Rice (CM)

Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH